ArticleClinical & translational immunology2026
Enhanced Fc and complement activity of Fc-modified avelumab boosts anti-tumor activity but promotes NK cell fratricide.
Lachlan J Dobson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.